AN2 Therapeutics ANTX
NASDAQ ANTX
$4.46 +0.13 (+3.00%)
At close: Nov 11, 2026 · 4:00 PM EST

AN2 Therapeutics (ANTX) Other Operating Expenses (2021 - 2022)

Updated

AN2 Therapeutics' Other Operating Expenses came in at $1 million for FY2022, up 33.3% from $750,000 in FY2021.

Analysis

AN2 Therapeutics (ANTX) Other Operating Expenses (2021 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put Other Operating Expenses at $750,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 AN2 Therapeutics 164.30 Mn -121.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 1.00 Mn
Dec 31, 2021 500,000.00
Jun 30, 2021 250,000.00
API Access

AN2 Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ANTX&period=max&api_key=YOUR_API_KEY